Show simple item record

dc.contributor.authorVerweij, Paul E.
dc.contributor.authorAnanda-Rajah, Michelle
dc.contributor.authorAndes, David
dc.contributor.authorArendrup, Maiken C.
dc.contributor.authorBruggemann, Roger J.
dc.contributor.authorChowdhary, Anuradha
dc.contributor.authorCornely, Oliver A.
dc.contributor.authorDenning, David W.
dc.contributor.authorGroll, Andreas H.
dc.contributor.authorIzumikawa, Koichi
dc.contributor.authorKullberg, Bart Jan
dc.contributor.authorLagrou, Katrien
dc.contributor.authorMaertens, Johan
dc.contributor.authorMeis, Jacques F.
dc.contributor.authorNewton, Pippa
dc.contributor.authorPage, Iain
dc.contributor.authorSeyedmousavi, Seyedmojtaba
dc.contributor.authorSheppard, Donald C.
dc.contributor.authorViscoli, Claudio
dc.contributor.authorDonnelly, J. Peter
dc.contributor.authorWarris, Aafje
dc.date.accessioned2016-09-16T12:00:04Z
dc.date.available2016-09-16T12:00:04Z
dc.date.issued2015
dc.identifier69012842
dc.identifieraa5efb09-ed29-47a9-bf88-a0ddd7c93774
dc.identifier000362060500004
dc.identifier84941317313
dc.identifier.citationVerweij , P E , Ananda-Rajah , M , Andes , D , Arendrup , M C , Bruggemann , R J , Chowdhary , A , Cornely , O A , Denning , D W , Groll , A H , Izumikawa , K , Kullberg , B J , Lagrou , K , Maertens , J , Meis , J F , Newton , P , Page , I , Seyedmousavi , S , Sheppard , D C , Viscoli , C , Donnelly , J P & Warris , A 2015 , ' International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus ' , Drug Resistance Updates , vol. 21-22 , pp. 30-40 . https://doi.org/10.1016/j.drup.2015.08.001en
dc.identifier.issn1368-7646
dc.identifier.urihttp://hdl.handle.net/2164/7487
dc.descriptionAcknowledgements We thank Gilead Sciences Europe Ltd., UK for financially supporting logistical aspects of this study. The logistics of the meeting were handled by Congress Care, Den Bosch, The Netherlands. The sponsor was not involved in the selection of the participants or procedures, or in the discussion, data collection, analysis or writing of the manuscript. The medical writer was financially supported by the Dutch Society for Medical Mycology and the Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.en
dc.format.extent11
dc.format.extent1120484
dc.language.isoeng
dc.relation.ispartofDrug Resistance Updatesen
dc.subjectAzole resistanceen
dc.subjectInvasive aspergillosisen
dc.subjectChronic aspergillosisen
dc.subjectAspergillus fumigatusen
dc.subjectVoriconazoleen
dc.subjectChronic pulmonary aspergillosisen
dc.subjectCentral-nervous-systemen
dc.subjectLiposomal amphotericin-Ben
dc.subjectPharmacodynamic Target Determinationen
dc.subjectBronchoalveolar lavage fluiden
dc.subjectAntifungal Therapyen
dc.subjectTR34/L98H Mutationsen
dc.subjectCYP51A geneen
dc.subjectWild-typeen
dc.subjectRS Pharmacy and materia medicaen
dc.subject.lccRSen
dc.titleInternational expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatusen
dc.typeJournal itemen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.MRC Centre for Medical Mycologyen
dc.description.statusPeer revieweden
dc.identifier.doi10.1016/j.drup.2015.08.001


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record